Railo M - Search Results

1

Use of somatostatin in biliary fistulas of transplanted livers.

Railo M, Salmela K, Isoniemi H, Kyllönen L, Höckerstedt K. Railo M, et al. Transplant Proc. 1992 Feb;24(1):391-3. Transplant Proc. 1992. PMID: 1539330 No abstract available.

2

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.

Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllönen L, von Smitten K. Railo M, et al. Br J Cancer. 1993 Sep;68(3):579-83. doi: 10.1038/bjc.1993.389. Br J Cancer. 1993. PMID: 8394732 Free PMC article.

3

Increased preoperative c-reactive protein level as a prognostic factor for postoperative amputation after femoropopliteal bypass surgery for CLI.

Mätzke S, Biancari F, Ihlberg L, Albäck A, Kantonen I, Railo M, Lepäntalo M. Mätzke S, et al. Among authors: railo m. Ann Chir Gynaecol. 2001;90(1):19-22. Ann Chir Gynaecol. 2001. PMID: 11336363

4

N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial.

Hynninen MS, Niemi TT, Pöyhiä R, Raininko EI, Salmenperä MT, Lepäntalo MJ, Railo MJ, Tallgren MK. Hynninen MS, et al. Anesth Analg. 2006 Jun;102(6):1638-45. doi: 10.1213/01.ANE.0000219590.79796.66. Anesth Analg. 2006. PMID: 16717300 Free article. Clinical Trial.

5

Does an adjuvant AV-fistula improve the patency of a femorocrural PTFE bypass with distal vein cuff in critical leg ischaemia?--a prospective randomised multicentre trial.

Laurila K, Lepäntalo M, Teittinen K, Kantonen I, Forssell C, Vilkko P, Nielsen OM, Railo M, Lehtola A; ScanPAC Study Group. Laurila K, et al. Among authors: railo m. Eur J Vasc Endovasc Surg. 2004 Feb;27(2):180-5. doi: 10.1016/j.ejvs.2003.12.003. Eur J Vasc Endovasc Surg. 2004. PMID: 14718901 Free article. Clinical Trial.

6

The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients.

Railo MJ, von Smitten K, Pekonen F. Railo MJ, et al. Eur J Cancer. 1994;30A(3):307-11. doi: 10.1016/0959-8049(94)90247-x. Eur J Cancer. 1994. PMID: 8204350

7

Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer.

Railo M, Lundin J, Haglund C, von Smitten K, Nordling S. Railo M, et al. Tumour Biol. 2007;28(1):45-51. doi: 10.1159/000097702. Epub 2006 Dec 1. Tumour Biol. 2007. PMID: 17143016

8

Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.

Railo M, Nordling S, Krogerus L, Sioris T, von Smitten K. Railo M, et al. Diagn Cytopathol. 1996 Sep;15(3):205-10. doi: 10.1002/(SICI)1097-0339(199609)15:3<205::AID-DC6>3.0.CO;2-F. Diagn Cytopathol. 1996. PMID: 8955602

9

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.

Railo M, Lundin J, Haglund C, von Smitten K, von Boguslawsky K, Nordling S. Railo M, et al. Acta Oncol. 1997;36(4):369-74. doi: 10.3109/02841869709001282. Acta Oncol. 1997. PMID: 9247096

10

The prognostic value of epidermal growth factor receptor (EGFR) in breast cancer patients. Results of a follow-up study on 149 patients.

Railo MJ, Smitten KV, Pekonen F. Railo MJ, et al. Acta Oncol. 1994;33(1):13-7. doi: 10.3109/02841869409098368. Acta Oncol. 1994. PMID: 8142117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page